OOIR: Observatory of International Research

Papers

(The TQCC of New England Journal of Medicine is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Striking a Balance — Advancing Physician Collective-Bargaining Rights and Patient Protections	3290
How Can We Fully Realize SNAP’s Health Benefits?	3136
Malnutrition in Adults	2582
Childhood Risk Factors and Adult Cardiovascular Events	2407
The Importance of Context in Covid-19 Vaccine Safety	1979
Evidence-Based Work Design — Bridging the Divide	1957
A Swell Diagnosis	1901
Automatic Insurance Policies — Important Tools for Preventing Coverage Loss	1760
Gantenerumab in Early Alzheimer’s Disease	1745
Race in Medicine — Genetic Variation, Social Categories, and Paths to Health Equity	1743
Implanted System for Orthostatic Hypotension in Multiple-System Atrophy	1692
Kidney Injury and Hair-Straightening Products Containing Glyoxylic Acid	1616
Optical Coherence Tomography and Eye Care	1558
Receipt of mRNA Vaccine against Covid-19 and Myocarditis	1521
Overcoming Resistance — Omission of Radiotherapy for Low-Risk Breast Cancer	1492
Prolonging Cellular Life after Hypoxic Death	1373
From the Eyeball Test to the Algorithm — Quality of Life, Disability Status, and Clinical Decision Making in Surgery	1325
Mucosal IgA against SARS-CoV-2 Omicron Infection	1251
Gastric Emptying Abnormalities in Diabetes Mellitus	1230
Middle Meningeal Artery Embolization for Subdural Hematoma	1226
Empagliflozin in Heart Failure with a Preserved Ejection Fraction	1218
Bronchiectasis — A Clinical Review	1185
Hypothermia or Machine Perfusion in Kidney Donors	1129
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype	1080
Exclusion of Elective Care from Hospital Financial Assistance Policies — Arresting a Troubling Development	1071

Nutritional Support for Moderate-to-Late–Preterm Infants — A Randomized Trial	1065
Striving for Diversity in Research Studies	1008
Cholelithiasis, Cholecystitis, and Choledocholithiasis	938
Gazing into a Crystal Ball	918
Automated Insulin Pump in Type 2 Diabetes	914
Catching Up on REMs	881
Foreign-Body Aspiration in a Child	881
Maintenance or Discontinuation of Antidepressants in Primary Care	850
Audio Interview: Dissecting the Host Response to SARS-CoV-2	840
Early Active Mobilization during Mechanical Ventilation in the ICU	832
Perioperative Durvalumab in Bladder Cancer	803
Effect of a Reduced PCV10 Dose Schedule on Pneumococcal Carriage in Vietnam	784
SENIOR-RITA — Is It All about Angiography?	782
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia	781
Postacute Sequelae of SARS-CoV-2 Infection in Several Eras	774
Targeting CSF1R in Chronic GVHD — Lessons in Translation	741
Race-Based Diagnosis, Part 1 — ITT Episode 33	736
Investigating Injustices in the Journal ’s History, Part 2	733
Tenecteplase for Stroke — Opening the Window?	733
Hemotympanum with a Basilar Skull Fracture	722
Secondary Hypertrophic Osteoarthropathy	718
Testing for Arginine Vasopressin Deficiency	707
Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors	703
Psychosocial Functioning in Transgender Youth after 2 Years of Hormones	697
U.S. Law and Discrimination in Health Care	679
Case 40-2022: A 38-Year-Old Man with Exertional Chest Discomfort	672
The Muffin Question	657
Hiding in Plain Sight	653
Bilothorax	647
Audio Interview: Assessing Bivalent Vaccines against Covid-19	645
A Modern Therapy for an Ancient Disease	643
Monoclonal Antibodies for Malaria	642
Nonketotic Hyperglycemic Hemichorea	626
Designing Cures 2.0 — From Corridors to Cornerstones	626
Gingival Infiltration in Acute Monocytic Leukemia	622
Hyperpigmentation in Vitamin B ₁₂ Deficiency	608
Use of Polygenic Scores to Select Embryos	604
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD	603
Alteplase and Thrombectomy — Not a Bridge to Dismantle	596
Primaquine and Plasmodium vivax Malaria Recurrence in Brazil	595
Ruxolitinib for Chronic Graft-versus-Host Disease	592
Breaking the Sacred Promise	591
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy	591
Ménétrier’s Disease	589
Nationwide, Couple-Based Genetic Carrier Screening	588
Rethinking Shadowing for Aspiring Physicians	588
Poet as Patient	581
Navigating and Communicating about Serious Illness and End of Life	577
Preparing for the Next Pandemic — Expanding and Coordinating Global Regulatory Capacity	575
Liver Transplantation for Mahvash Disease, an Inborn Error of Metabolism	575

Adrenal Involvement in Disseminated Histoplasmosis	574
Multicentric Reticulohistiocytosis	556
Zilebesiran for Hypertension	554
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure	553
Black Dot Tinea Capitis	552
Ten Years of Incidental, Secondary, and Actionable Findings	550
Screening for Prostate Cancer	533
Timing Is Everything — Evidence for When to Perform Complete Revascularization in STEMI	523
Turning CMS into a Health Technology Assessment Organization	520
Convalescent Rash of Dengue	520
Modifiable Risk Factors and Cardiovascular Outcomes	517
Bismuth Subsalicylate Poisoning	512
Early Treatment with Sotrovimab for Covid-19	511
Bumps in the Road	506
Covid-19 Infections in Vaccinated Health Care Workers	506
A Trial of Trimethoprim–Sulfamethoxazole in Pregnancy to Improve Birth Outcomes	505
Debating Race and the Diagnosis of Anemia — How Medicine Moved Away from Race-Based Standards	505
Paget’s Disease of the Breast	501
Case 18-2025: A 63-Year-Old Woman with Dyspnea on Exertion	499
Threatening the Future of Global Health — NIH Policy Changes on International Research Collaborations	499
Use of Wastewater for Mpox Outbreak Surveillance in California	497
Out of Pocket Getting Out of Hand — Reducing the Financial Toxicity of Rapidly Approved Drugs	496
Virotherapy for Brain Tumors — Defining the Path to Success	495
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk	488
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B	488
Lung Transplantation for Covid-19–Related Respiratory Failure in the United States	488
New Horizons in the Treatment of Osteosarcoma	488
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction	480
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer	478
Navigating and Communicating about Serious Illness and End of Life	475
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR	471
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma	470
Pulse Oximetry for Monitoring Patients with Covid-19 at Home — A Pragmatic, Randomized Trial	466
Haloperidol for the Treatment of Delirium in ICU Patients	466
Periprosthetic Joint Infection	465
Fever of Unknown Origin	465
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer	464
Reteplase versus Alteplase for Acute Ischemic Stroke	459
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia	453
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts	439
Spontaneous Intracranial Hypotension	438
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile	437
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia	432
Association between Covid-19 Vaccination and Influenza Vaccination Rates	430
Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone	430
Disappearing Data at the U.S. Federal Government	425
Extending Cancer Survival with Exercise — Time for Oncology to Act	424
Postherpetic Abdominal Pseudohernia	424
Increasing Firearm-Related Deaths among U.S. Black Rural Youths	422
Covid-19 Surveillance Testing in Nursing Homes	420
Hospital Problems	418
Pegylated Interferon Lambda for Covid-19	413
Trials for Managing Acute Pain — A Clinically Meaningful Small Effect Size?	410
Guilty	409
PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer	403
Transfusion Strategy in Myocardial Infarction and Anemia	400
Water-Based and Waterless Surgical Scrub Techniques	399
Case 39-2023: A 43-Year-Old Woman with Chronic Diarrhea, Hair Loss, and Nail and Skin Changes	396
Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis — Past, Present, and Future	395
Focused Cardiac Ultrasonography for Right Ventricular Size and Systolic Function	394
Routine Removal of Inferior Vena Cava Filters	394
The Increasing Incidence of Early-Onset Colorectal Cancer	392
Case 26-2022: A 48-Year-Old Woman with Cystic Lung Disease	390
Pretomanid in the Treatment of Patients with Tuberculosis in the United States	388
Diagnostic Aspirations	376
Audio Interview: Ending the Covid-19 Public Health Emergency	376
End of a Declared Public Health Emergency — Implications for U.S. Emergency Use Authorizations	375
Small Step or Giant Leap? Expanding the Acute Stroke Thrombolysis Window to 24 Hours	375
Expect With Me — Group Prenatal Care to Reduce Disparities	371
Genital Herpes Zoster	371
HIPAA and the Leak of “Deidentified” EHR Data	368
NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction	365
The Death of an Unlikable Man	365
Intravenous Amino Acids and Kidney Protection	364
Invasive Strategy for Older Patients with MI	361
FINEARTS-HF — The Latest Masterpiece for MRAs in Heart Failure	360
Crinecerfont in Adult Congenital Adrenal Hyperplasia	359
Autoantibodies Targeting Nephrin in Podocytopathies	356
Case 38-2024: A 22-Year-Old Woman with Headache, Fever, and Respiratory Failure	355
Guidance on Energy and Macronutrients across the Life Span	354

Criminalizing Homelessness — The Grants Pass, Oregon, Supreme Court Case	350
Felzartamab in Antibody-Mediated Rejection	346
Academic Freedom in America — In Support of Institutional Voices	345
Making Long-Term Oxygen Therapy Less Burdensome	344
Medication for Gastroesophageal Reflux Disease in Infants	343
Broken Both Ways	342
Chylothorax	342
Vocal-Cord Polyp Causing Airway Obstruction	342
Convalescent Plasma for Covid-19–Induced ARDS	340
Gastric Syphilis	339
What We Don’t Know about School Shooter Drills	337
Helicobacter pylori , Homologous-Recombination Genes, and Gastric Cancer	337
A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?	337
Public Health’s Role in a Post- Dobbs World — The New York City Abortion Access Hub	336
Case 21-2023: A 61-Year-Old Man with Eyelid Swelling	336
Moving the Needle on Alzheimer’s Disease with an Anti-Oligomer Antibody	335
Case 5-2023: A 67-Year-Old Man with Interstitial Lung Disease, Fever, and Myalgias	335
Personality Disorders	334
Cholesterol Pericarditis	332
Audio Interview: Rolling Out New Covid-19 Vaccines	331
Atrial Fibrillation — What Is It and How Is It Treated?	331
HIV Prevention and the 340B Drug Pricing Program	330
Japanese Spotted Fever	329
Booster Doses and Prioritizing Lives Saved	327
Benefits and Risks of Iron Interventions in Infants in Bangladesh	325
Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells	322
Vaccine Effectiveness Studies in the Field	320
SGLT2 Inhibitors and False Positive Toxicology Tests	316
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6	315
Tuberculous Meningitis — New Approaches Needed	313
Skeletal Fluorosis	312
Targeting HER2 -Mutant NSCLC — The Light Is On	311
Gustatory Hyperhidrosis after Parotid Surgery	303
Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas	303
Compared with What? Measuring AI against the Health Care We Have	302
Audio Interview: The Omicron Variant of SARS-CoV-2	302
Laryngeal Candidiasis	301
The IARC Perspective on Cervical Cancer Screening	300
Advanced HIV as a Neglected Disease	300
The Risks of Normalizing Parental Vaccine Hesitancy	299
Methylprednisolone for Heart Surgery in Infants — A Randomized, Controlled Trial	298
New Perioperative Strategy in Gastric Cancer	297
Aspergillus Infections	296
Transforming Management of Opioid Use Disorder with Universal Treatment	296
Medication-Associated Diethylene Glycol Mass Poisoning — A Preventable Cause of Illness and Death	293
Audio Interview: Ending the Covid-19 Emergency	291
Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia	289
Bivalent Covid-19 Vaccines — A Cautionary Tale	288
Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial	288
A Preview of the Dangerous Future of Abortion Bans — Texas Senate Bill 8	288
Emodepside for Trichuris trichiura and Hookworm Infection	287
Cardiac Implantable Electronic Devices	286
Behçet’s Syndrome	285
Mycoplasma-Induced Rash and Mucositis	283
“Putting America First” — Undermining Health for Populations at Home and Abroad	280
A Zoonotic Henipavirus in Febrile Patients in China	277
Targeting Lipoprotein(a) — the Next Frontier in Cardiovascular Disease	274
Early Outpatient Treatment for Covid-19 with Convalescent Plasma	274
Betibeglogene Autotemcel Gene Therapy for Non–β ⁰ /β ⁰ Genotype β-Thalassemia	271
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B	271
Neurovascular Complications of Iatrogenic Fusarium solani Meningitis	270
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer	269
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis	269
Chronic Traumatic Encephalopathy in the Brains of Military Personnel	267
Immune Checkpoint Inhibitors — The Need for Innovation	266
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction	266
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction	265
Artificial Intelligence in Medicine	263
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity	260
A Dual-Chamber Leadless Pacemaker	259
What’s in a Number? Breaking Down the Residency Match Rate	258
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma	258
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults	258
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use	258
Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease	257
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer	257
Genetically Modified Porcine-to-Human Cardiac Xenotransplantation	257
Autoantibodies Targeting Nephrin in Podocytopathies	255
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes	254
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma	254
Waning Immunity after the BNT162b2 Vaccine in Israel	253
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy	252
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension	252
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation	252
Monkeypox	251
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation	251
TAVR for Asymptomatic Severe Aortic Stenosis	250
Aspiration Thrombectomy for Coronary Stent Thrombosis	247
Health Care in an Evolving Immigration Landscape — Providing Care while Upholding the Law	245
Transparency and the Doctor–Patient Relationship — Rethinking Conflict-of-Interest Disclosures	244
A “Fluid” Diagnosis	243
Case 37-2021: A 60-Year-Old Man with Fevers, Fatigue, Arthralgias, a Mouth Ulcer, and a Rash	243
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant	240
On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons	238
The No Surprises Act and Informed Financial Consent	238